Inovio Pharmaceuticals Reaches Analyst Target Price
February 02, 2021 at 09:26 AM EST
In recent trading, shares of Inovio Pharmaceuticals Inc. (INO) have crossed above the average analyst 12-month target price of $14.17, changing hands for $16.96/share..